🟢 VERU is trading 6.3% up today, extending a rebound, also added to Russell Microcap Value Benchmark Index

VERU is trading at $3.20 (6.3% up), extending a rebound following its early-June spike on a Novo Nordisk clinical supply deal.

• The company was added to the Russell Microcap Value Benchmark Index today, providing fresh company-specific support.
• Follow-through interest in the company's obesity-trial narrative and broader risk-on market sentiment are also contributing factors.